Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ESAs not the culprit: more studies required.
Ludwig H, Anderson K, Dammacco F, Hedenus M, Osterborg A, Durie B. Ludwig H, et al. Among authors: hedenus m. Am J Hematol. 2008 Nov;83(11):880; author reply 880-1. doi: 10.1002/ajh.21270. Am J Hematol. 2008. PMID: 18785638 Free article. No abstract available.
Too-low iron doses and too many dropouts in negative iron trial?
Aapro M, Beguin Y, Birgegård G, Gascón P, Hedenus M, Osterborg A. Aapro M, et al. Among authors: hedenus m. J Clin Oncol. 2011 Jun 10;29(17):e525-6; author reply e527-8. doi: 10.1200/JCO.2011.35.3219. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537041 Free article. No abstract available.
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.
Vansteenkiste J, Hedenus M, Gascon P, Bokemeyer C, Ludwig H, Vermorken J, Hamilton L, Bridges K, Pujol B. Vansteenkiste J, et al. Among authors: hedenus m. BMC Cancer. 2009 Sep 3;9:311. doi: 10.1186/1471-2407-9-311. BMC Cancer. 2009. PMID: 19728887 Free PMC article. Clinical Trial.
Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies.
de Boer R, Clemens M, Renczes G, Kotasek D, Prausova J, Marschner N, Hedenus M, Doshi S, Hendricks L, Österborg AC. de Boer R, et al. Among authors: hedenus m. Med Oncol. 2011 Dec;28(4):1210-7. doi: 10.1007/s12032-010-9725-7. Epub 2010 Oct 29. Med Oncol. 2011. PMID: 21046285 Clinical Trial.
38 results